LMWH Comparative Tables    body {font-family: 'Open Sans', sans-serif;}

### LMWH Comparative Tables

table.tableizer-table { font-size: 12px; border: 1px solid #CCC; font-family: Arial, Helvetica, sans-serif; } .tableizer-table td { padding: 4px; margin: 3px; border: 1px solid #CCC; } .tableizer-table th { background-color: #104E8B; color: #FFF; font-weight: bold; }

|  | Enoxaparin | Dalteparin | Tinzaparin |
| --- | --- | --- | --- |
| Brand name | Lovenox | Fragmin | Innohep |
| Manufacturer | Sanofi-Aventis | Pfizer  
(for Eisai) | Leo  
(formerly DuPont) |
| Mean molecular weight  
(daltons) | 4,500 | 6,000 | 6,500 |
| Elimination half-life  
(hours) | 4.5 | 3-5 | 3.4 |
| Bioavailability (%) | 90-92 | 87 | 87 |
| Anti-Xa/anti-IIa ratio | 3.8 | 2.7 | 2.8 |
| Anti-Xa activity (IU/mg) | 100 | 156 | 100 |

Merli GJ, Vanscoy GJ, Rihn TL, et al.  _J Thromb Thrombolysis_  2001;11:247–259  
  
  
**The shorter the fragments, the more specific the drug is for Factor Xa**

table.tableizer-table { font-size: 12px; border: 1px solid #CCC; font-family: Arial, Helvetica, sans-serif; } .tableizer-table td { padding: 4px; margin: 3px; border: 1px solid #CCC; } .tableizer-table th { background-color: #104E8B; color: #FFF; font-weight: bold; }

| Anticoagulant | Mean Molecular Mass | Anti FXa/FIIa  
(anti-FXa IU/mg) | Anti FXa/FIIa ratio |
| --- | --- | --- | --- |
| UFH | 15 kDa | 193/193 | 1 |
| Tinzaprin (Innohep) | 6.8 kDa | 90/45 | 2.0 |
| Dalteparin (Fragmin) | 6.0 kDa | 130/52 | 2.5 |
| Enoxaparin (Lovenoz) | 4.2 kDa | 100/25 | 3.9 |
| Fondaparinux (Arixtra)  
See note below. | 1.7 kDa | 930/0 |  |

**_Note-Fondaparinux (Arixtra)_** _is an anticoagulant that shares the same pentasaccharide sequence as UFH and LMWH for the binding to antithrombin, however it has no extra chain and thus, is not considered a heparin product. It is also known to not cause HIT, as seen with UFH and LMWH._